2018
DOI: 10.3390/molecules23123170
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Experimental and Density Functional Theory (DFT) Studies on Solubility of Camptothecin Derivatives

Abstract: Two camptothecin derivatives, 10-cyclohexyl-7-methyl-20(S)-camptothecin and 7-methyl-10-morpholino-20(S)-camptothecin, were synthesized and their differences in solubility were investigated using four chosen solvent systems. Based on our results, 10-cyclohexyl-7-methyl-20(S)-camptothecin exhibited higher solubilities than 7-methyl-10-morpholino-20(S)-camptothecin in polar aprotic solvents. However, these two camptothecin derivatives did not exhibit apparent differences in solubility between 5% dimethyl sulfoxi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…It has been demonstrated to have remarkable antitumor effects against liver, gastrointestinal, bladder, and prostate cancers as well as certain types of leukemia by blocking the synthesis of the DNA enzyme topo-isomerase [2,3]. Semi-synthetic derivatives of CPT, such as topotecan (hycamtin) and irinotecan (CPT-11), have been employed as anticancer therapeutic agents and approved by Food and Drug Administration (FDA) [4,5]. However, the systemic toxicity of CPT, low aqueous solubility, low bioavailability, and inappropriate drug-targeting remain the major challenges associated with chemotherapeutic results [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…It has been demonstrated to have remarkable antitumor effects against liver, gastrointestinal, bladder, and prostate cancers as well as certain types of leukemia by blocking the synthesis of the DNA enzyme topo-isomerase [2,3]. Semi-synthetic derivatives of CPT, such as topotecan (hycamtin) and irinotecan (CPT-11), have been employed as anticancer therapeutic agents and approved by Food and Drug Administration (FDA) [4,5]. However, the systemic toxicity of CPT, low aqueous solubility, low bioavailability, and inappropriate drug-targeting remain the major challenges associated with chemotherapeutic results [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Qualitatively, the fluorescence emitted by the additional CPT in solution could be readily visualized by simply illuminating the sample with a hand-held lamp (Figure 8c). Quantitative measurements found the drug loading efficiency to be 0.22% with a 10-fold improvement in aqueous solubility from 8.4 ng/mL, 59 to 75 ng/mL (see Supporting Information). The next step was to determine if a formulation of HBPn• CPT enhanced delivery of CPT into cells and induced a higher toxic effect.…”
Section: ■ Results and Discussionmentioning
confidence: 99%